Joseph J. Locascio

Joseph J. Locascio

Auto-generated profile, based on publicly available information

Joseph J. Locascio

Department of Neurology, Harvard Catalyst Biostatistical Group, Massachusetts General Hospital, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Science
Verified
Journal Article
Closed access
PDF file
SMShuchi Mittal
Shuchi Mittal
KBKjetil Bjørnevik
Kjetil Bjørnevik
DIDoo Soon Im
Doo Soon Im
AFAdrian Flierl
Adrian Flierl
XDXianjun Dong
Xianjun Dong
CSClemens R. Scherzer
Clemens R. Scherzer
Elucidating the risk of Parkinson's disease: High expression of the α-synuclein gene ( SNCA ) is a risk factor for Parkinson's disease (PD), but certain drugs may mitigate this risk. Mittal et al. ran a small-molecule screen to identify compounds that regulate levels of SNCA expression and found that several β2-adrenoreceptor (β2AR) agonists reduced them (see the Perspective by Snyder). These compounds modulated epigenetic marks at the SNCA gene, effectively suppressing SNCA transcription. The authors looked at the pharmaceutical history of more than 4 million Norwegians over an 11-year period and found a reduced risk of PD among those that were taking one of the β2AR agonists for other medical problems. Science , this issue p. 891 ; see also p. 869

11 November 2011 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
SSSteven D Shirk
Steven D Shirk
MMMeghan B Mitchell
Meghan B Mitchell
LSLynn W Shaughnessy
Lynn W Shaughnessy
JSJanet C Sherman
Janet C Sherman
JLJoseph J Locascio
Joseph J Locascio
AAAlireza Atri
Alireza Atri
Introduction: With the recent publication of new criteria for the diagnosis of preclinical Alzheimer's disease (AD), there is a need for neuropsychological tools that take premorbid functioning into account in order to detect subtle cognitive decline. Using demographic adjustments is one method for increasing the sensitivity of commonly used measures. We sought to provide a useful online z-score calculator that yields estimates of percentile ranges and adjusts individual performance based on sex, age and/or education for each of the neuropsychological tests of the National Alzheimer's Coordinating Center Uniform Data Set (NACC, UDS). In addition, we aimed to provide an easily accessible method of creating norms for other clinical researchers for their own, unique data sets. Methods: Data from 3,268 clinically cognitively-normal older UDS subjects from a cohort reported by Weintraub and colleagues (2009) were included. For all neuropsychological tests, z-scores were estimated by subtracting the raw score from the predicted mean and then dividing this difference score by the root mean squared error term (RMSE) for a given linear regression model. Results: For each neuropsychological test, an estimated z-score was calculated for any raw score based on five different models that adjust for the demographic predictors of SEX, AGE and EDUCATION, either concurrently, individually or without covariates. The interactive online calculator allows the entry of a raw score and provides five corresponding estimated z-scores based on predictions from each corresponding linear regression model. The calculator produces percentile ranks and graphical output. Conclusions: An interactive, regression-based, normative score online calculator was created to serve as an additional resource for UDS clinical researchers, especially in guiding interpretation of individual performances that appear to fall in borderline realms and may be of particular utility for operationalizing subtle cognitive impairment present according to the newly proposed criteria for Stage 3 preclinical Alzheimer's disease.

26 October 2011 in Dementia and Geriatric Cognitive Disorders Extra
Verified
Journal Article
Open access
PDF file
JLJoseph J. Locascio
Joseph J. Locascio
AAAlireza Atri
Alireza Atri
The purpose of this article is to provide a concise, broad and readily accessible overview of longitudinal data analysis methods, aimed to be a practical guide for clinical investigators in neurology. In general, we advise that older, traditional methods, including (1) simple regression of the dependent variable on a time measure, (2) analyzing a single summary subject level number that indexes changes for each subject and (3) a general linear model approach with a fixed-subject effect, should be reserved for quick, simple or preliminary analyses. We advocate the general use of mixed-random and fixed-effect regression models for analyses of most longitudinal clinical studies. Under restrictive situations or to provide validation, we recommend: (1) repeated-measure analysis of covariance (ANCOVA), (2) ANCOVA for two time points, (3) generalized estimating equations and (4) latent growth curve/structural equation models.

1 June 2008 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
JLJoseph J. Locascio
Joseph J. Locascio
HFHiroaki Fukumoto
Hiroaki Fukumoto
LYLiang Yap
Liang Yap
TBTeodoro Bottiglieri
Teodoro Bottiglieri
JGJohn H. Growdon
John H. Growdon
MIMichael C. Irizarry
Michael C. Irizarry
Alzheimer disease (AD) is a dementing illness with a mean duration of 8 to 10 years after the onset of memory impairment.1 The course of AD is relentlessly progressive, although the rate of progression of AD is highly variable; the standard deviation of the yearly decline in many continuous cognitive and functional measures is of the same magnitude as the mean rate of decline. For example, AD is associated with a mean (SD) worsening of 3 (4) points per year on the Mini-Mental Status Examination (MMSE); 3 (3) points per year on the Blessed Dementia Scale (BDS), Information-Memory-Concentration subscale (BDS); 9 (9) points per year on the cognitive subscale of the AD Assessment Scale; and 10% (10%) decline per year on the Weintraub AD-specific Activities of Daily Living (ADL) Scale.2-4 Clinical characteristics associated with more rapid decline in AD include early language impairment, psychiatric symptoms, and extrapyramidal features.2 Male sex, high educational achievement, early age at disease onset, and the apolipoprotein E (APOE) ε4 allele are inconsistently associated with more rapid rate of decline in AD.2,5,6 However, these demographic, clinical, and genetic factors explain only a small fraction of the variability in rates of progression. We hypothesized that biochemical measures of plasma proteins or metabolites implicated in AD risk can predict progression and account for some of the variability in rate of decline.

15 March 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
NONicolas M Oreskovic
Nicolas M Oreskovic
JPJames M Perrin
James M Perrin
ARAlyssa I Robinson
Alyssa I Robinson
JLJoseph J Locascio
Joseph J Locascio
JBJeff Blossom
Jeff Blossom
EGElizabeth Goodman
Elizabeth Goodman
Physical activity is a health-enhancing behavior, but few adolescents achieve the recommended levels of moderate-to-vigorous physical activity. Understanding how adolescents use different built environment spaces for physical activity and activity varies by location could help in designing effective interventions to promote moderate-to-vigorous physical activity. The objective of this study was to describe the locations where adolescents engage in physical activity and compare traditional intensity-based measures with continuous activity when describing built environment use patterns among adolescents. Eighty adolescents aged 11–14 years recruited from community health and recreation centers. Adolescents wore accelerometers (Actigraph GT3X) and global positioning system receivers (QStarz BT-Q1000XT) for two separate weeks to record their physical activity levels and locations. Accelerometer data provided a continuous measure of physical activity and intensity-based measures (sedentary time, moderate-to-vigorous physical activity). Physical activity was mapped by land-use classification (home, school, park, playground, streets & sidewalks, other) using geographic information systems and this location-based activity was assessed for both continuous and intensity-based physical activity derived from mixed-effects models which accounted for repeated measures and clustering effects within person, date, school, and town. Mean daily moderate-to-vigorous physical activity was 22 minutes, mean sedentary time was 134 minutes. Moderate-to-vigorous physical activity occurred in bouts lasting up to 15 minutes. Compared to being at home, being at school, on the streets and sidewalks, in parks, and playgrounds were all associated with greater odds of being in moderate-to-vigorous physical activity and achieving higher overall activity levels. Playground use was associated with the highest physical activity level (β = 172 activity counts per minute, SE = 4, p < 0.0001) and greatest odds of being in moderate-to-vigorous physical activity (odds ratio 8.3, 95% confidence interval 4.8-14.2). Adolescents were more likely to engage in physical activity, and achieved their highest physical activity levels, when using built environments located outdoors. Novel objective methods for determining physical activity can provide insight into adolescents’ spatial physical activity patterns, which could help guide physical activity interventions. Promoting zoning and health policies that encourage the design and regular use of outdoor spaces may offer another promising opportunity for increasing adolescent physical activity.

3 September 2017 in Basic and Applied Social Psychology
Verified
Journal Article
Closed access
JLJoseph J. Locascio
Joseph J. Locascio
Problems in science publishing involving publication bias, null hypothesis significance testing (NHST), and irreproducibility of reported results have been widely cited. Numerous attempts to ameliorate these problems have included statistical methods to assess and correct for publication bias, and recommendation or development of statistical methodologies to replace NHST where some journals have even instituted a policy of banning manuscripts reporting use of NHST. In an effort to mitigate these problems, a policy of “results blind evaluation” of manuscripts submitted to journals is recommended, in which results reported in manuscripts are given no weight in the decision as to the suitability of the manuscript for publication. Weight would be given exclusively to (a) the judged importance of the research question addressed in the study, typically conveyed in the Introduction section of the manuscript, and (b) the quality of the methodology of the study, including appropriateness of data analysis methods, as reported in the Methods section. As a practical method of implementing such a policy, a two-stage process is suggested whereby the editor initially distributes only the Introduction and Methods sections of a submitted manuscript to reviewers for evaluation and a provisional decision regarding acceptance or rejection for publication is made. A second stage of review follows in which the complete manuscript is distributed for review but only if the decision of the first stage is for acceptance with no more than minor revision.